_this-biotech-company39s-lead-candidate-treats-rare-cancers-as-well-as-covid-19.jpg "This Biotech Company's Lead Candidate Treats Rare Cancers As Well As Covid-19 from masque covid 19 Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 10:5
👁 View: 260K times
✓ Published: 01-Jun-2024
👁 View: 260K times
✓ Published: 01-Jun-2024
Description:
Dr. Trieu, CEO of Oncotelic Therapeutics, was recently a guest on Benzinga's All Access.<br/><br/>Oncotelic seeks to improve the outcomes and survival of cancer patients, with a special emphasis on rare pediatric cancers. Its lead asset, OT-101, has a rare pediatric designation for diffuse intrinsic pontine glioma. The company has a host of IPs that are being studied in indications as diverse as leukemia, Parkinson’s Disease and erectile dysfunction.<br/><br/>Mr. Trieu spoke about the nanomedicine platform his company is currently building out.
Dr. Trieu, CEO of Oncotelic Therapeutics, was recently a guest on Benzinga's All Access.<br/><br/>Oncotelic seeks to improve the outcomes and survival of cancer patients, with a special emphasis on rare pediatric cancers. Its lead asset, OT-101, has a rare pediatric designation for diffuse intrinsic pontine glioma. The company has a host of IPs that are being studied in indications as diverse as leukemia, Parkinson’s Disease and erectile dysfunction.<br/><br/>Mr. Trieu spoke about the nanomedicine platform his company is currently building out.
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_will-mask-mandates-return-as-covid-19-cases-rise.webp "Inside Edition")
_the-best-mask-or-diy-face-covering-for-covid-19.webp "NutritionFacts.org")
_this-biotech-company39s-lead-candidate-treats-rare-cancers-as-well-as-covid-19.webp "Dr. Trieu, CEO of Oncotelic Therapeutics, was recently a guest on Benzinga's All Access.<br/><br/>Oncotelic seeks to improve the outcomes and survival of cancer patients, with a special emphasis on rare pediatric cancers. Its lead asset, OT-101, has a rare pediatric designation for diffuse intrinsic pontine glioma. The company has a host of IPs that are being studied in indications as diverse as leukemia, Parkinson’s Disease and erectile dysfunction.<br/><br/>Mr. Trieu spoke about the nanomedicine platform his company is currently building out.")
_covid-19-124-mask-related-skin-problems.webp "UW Health")
Related Video Searches
Back to Search
Search Videos
Recent Searches
×
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
_will-mask-mandates-return-as-covid-19-cases-rise.jpg)
_the-best-mask-or-diy-face-covering-for-covid-19.jpg)
_covid-19-124-mask-related-skin-problems.jpg)
❮❯
1 / 6
2 / 6
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
3 / 6
4 / 6
5 / 6
6 / 6
View Full Screen: this biotech company39s lead candidate treats rare cancers as well as covid 19.jpg
![[+]](/images/menu.gif){kind=small}